PD Dr. Marlen Haderlein

Medizinische Fakultät Department of Radiation Oncology

Pilot Project for App-based Patient Connection in outpatient Tumor Therapy (2022) Hecht M, Goldbrunner L, Kaul F, Winkler S, Ploner N, Lettmaier S, Haderlein M, et al. Conference contribution In the Case of Radiochemotherapy of advanced Rectal Cancer, there is only slight gender-related Differences, none in terms of Radiation Sensitivity! (2022) Schuster B, Hecht M, Schmidt M, Haderlein M, Jost T, Geinitz H, Fietkau R, Distel L Conference contribution Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer (2022) Müller SK, Haderlein M, Lettmaier S, Agaimy A, Haller F, Hecht M, Fietkau R, et al. Journal article, Review article The Prognostic Value of FoxP3+Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+Cytotoxic T Cell Density (2022) Schnellhardt S, Hirneth J, Büttner-Herold M, Daniel C, Haderlein M, Hartmann A, Fietkau R, Distel L Journal article Influence of gender on radiosensitivity during radiochemotherapy of advanced rectal cancer (2022) Schuster B, Hecht M, Schmidt M, Haderlein M, Jost T, Büttner-Herold M, Weber K, et al. Journal article Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites? (2021) Weissmann T, Höfler D, Hecht M, Semrau S, Haderlein M, Filimonova I, Frey B, et al. Journal article Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors (2021) Griewing LM, Schweizer C, Schubert P, Rutzner S, Eckstein M, Frey B, Haderlein M, et al. Journal article Reduction of elective radiotherapy treatment volume in definitive treatment of locally advanced head and neck cancer—comparison of a prospective trial with a revised simulated contouring approach (2021) Weissmann T, Speer S, Putz F, Lettmaier S, Schubert P, Shariff M, Semrau S, et al. Journal article Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice (2021) von der Grün J, Roedel C, Semrau S, Balermpas P, Martin D, Fietkau R, Haderlein M Journal article Therapies for synchronous malignomas - the importance of interdisciplinary oncology (2021) Müller SK, Haderlein M, Traxdorf M, Semrau S, Agaimy A, Lettmaier S, Gostian AO, et al. Journal article, Editorial